Inicio › Ateroesclerosis › California

Ensayos clínicos de Ateroesclerosis en California

11 estudios sobre Ateroesclerosis buscan participantes en California.

Ciudades en California

Texto oficial del estudio (inglés)

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

Thrive Clinical Research Group, LLC, Covina
Clinical Trials Research, Lincoln
University of California Irvine Medical Center - Cardiovascular Center, Los Alamitos
y 2 más

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07521007

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
Valley Clinical Trials, Inc., Northridge
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance

ReclutandoFase 3

Edades de 45 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07613294

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Thrive Clinical Research Group, Glendora

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Cardiovascular Research Foundation of Southern California, Beverly Hills
National Heart Institute, Beverly Hills
Amnova Clinical Research, Irvine
y 3 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

National Heart Institute, Beverly Hills
John Muir Medical Center - Concord Campus, Concord
Neighborhood Healthcare Institute of Health, Escondido
y 9 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07157774

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

National Institute of Clinical Research, Bakersfield
California Institute of Renal Research, Chula Vista
The Medical Research Group, Inc., Fresno
y 27 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Beverly Hills
Research Site, Canoga Park
Research Site, Castroville
y 26 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT07000357

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

Keck School of Medicine, University of Southern California, Los Angeles

Reclutando

Edades de 65 a 84 · Todos los sexos · Actualizado el 8 jun 2026 · NCT05867381

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda
VA Long Beach Healthcare System, Long Beach, CA, Long Beach
VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto
y 2 más

ReclutandoFase 4

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 dic 2025 · NCT02915198

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

UCLA Center for Clinical AIDS Research and Education (CARE), Los Angeles
San Francisco General Hospital, San Francisco

ReclutandoFase 2

Edades de 40 en adelante · Todos los sexos · Actualizado el 17 dic 2025 · NCT05488431

Text Education About Cardiovascular Health and HIV (TEACH-HIV)

Zuckerberg San Francisco General Hospital, San Francisco
University of California San Francisco, San Francisco

Reclutando

Edades de 40 en adelante · Todos los sexos · Actualizado el 8 jun 2025 · NCT05642858

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.